Pay in 4 interest-free payments of $7.41 Learn more
Ships within 48 hours · Estimated delivery Aug 31 - Sep 5
Since Wegovy's 2021 launch and Zepbound's approval five months ago, Novo Nordisk and Eli Lilly are leading the next generation of weight-loss drugs, targeting a market projected to reach $150bn by 2030
This product is intended for research use only
OGOmed is committed to providing dependable research materials, transparent product information, and a smooth purchasing experience for laboratories and trained personnel seeking trusted peptide products.
Site of metastasis Liver, lung, intestine, pancreas, adrenal, heart, kidney, brain, spleen, thyroid
US$ 22.02
:max_bytes(150000):strip_icc()/WhatstheDifferenceBetweenOzempicWegovyandMounjaro-illo-a8f5a23fe4914586b4488472fe15f112.png)
US$ 23.28
US$ 25.39
US$ 28.84
